Johnson & Johnson (J&J) has been hit with a US multimillion-dollar jury verdict for the fourth time over whether the talc in its baby powder causes ovarian cancer when applied regularly for feminine hygiene.
A St Louis, Missouri, jury on Thursday awarded US$110.5 million to Lois Slemp, 62, of Wise, Virginia, who was diagnosed with ovarian cancer in 2012. She blames her illness on her use of the company’s talcum powder-containing products for more than 40 years.
Besides Slemp’s case, three other jury trials in St Louis reached similar outcomes last year, awarding the plaintiffs US$72 million, US$70.1 million and US$55 million, for a combined total of US$307.6 million.
Photo: AP
The company said its product is safe and it plans to appeal the latest verdict, as it has the other three.
Johnson & Johnson also has had some legal victories, including in March when a St Louis jury rejected the claims of a Tennessee woman with ovarian and uterine cancer.
Also, two cases in New Jersey were thrown out by a judge who said the plaintiffs’ lawyers had not presented reliable evidence that talc leads to ovarian cancer.
The next baby powder trial is next month in St Louis and is to be followed by another in July in California.
Investors do not seem worried that J&J is in financial trouble, even though the company faces an estimated 2,000 similar lawsuits.
J&J shares fell US$0.62 to US$123.1 in late-afternoon trading on Friday.
J&J, the world’s biggest maker of healthcare products, brings in about US$72 billion a year selling prescription drugs, medical devices, diagnostic equipment and consumer products ranging from baby shampoo and Aveeno skin care items to Tylenol pain reliever and Band-Aids.
Because of its size and diversified product lines, J&J is sued frequently and investors do not panic when it loses product liability lawsuits, so its stock price rarely drops much after losses. Also, the company clearly intends to keep fighting lawsuits alleging its iconic baby powder is not safe, rather than settling suits at this point.
Talc is a mineral that is mined from deposits around the world, including the US. The softest of minerals, it is crushed into a white powder. It has been widely used in cosmetics and other personal care products to absorb moisture since at least 1894, when Johnson & Johnson’s Baby Powder was launched, but it is mainly used in a variety of other products, including paint and plastics.
Like many questions in science, there is no definitive answer. Finding the cause of cancer is difficult. It would be unethical to do the best kind of study, asking a group of women to use talcum powder on their genitals and wait to see if it causes cancer, while comparing them with a group who did not use it.
While ovarian cancer is often fatal, it is relatively rare. It accounts for only about 22,400 of the 1.7 million new cases of cancer expected to be diagnosed in the US this year.
Factors that are known to increase a women’s risk of ovarian cancer include age, obesity, use of estrogen therapy after menopause, not having any children, certain genetic mutations and personal or family history of breast or ovarian cancer.
TECH TITANS: Amazon’s latest chip joins Google in competing for the 90 percent market share held by Nvidia, which claims it is ‘a generation ahead of the industry’ Amazon Web Services (AWS) on Tuesday launched its in-house-built Trainium3 artificial intelligence (AI) chip, marking a significant push to compete with Nvidia Corp in the lucrative market for AI computing power. The move intensifies competition in the AI chip market, where Nvidia dominates with an estimated 80 to 90 percent market share for products used in training large language models that power the likes of ChatGPT. Google last week caused tremors in the industry when it was reported that Facebook-parent Meta Platforms Inc would employ Google AI chips in data centers, signaling new competition for Nvidia. This followed the release last month of
INSULATED: The company said it is less exposed to global complications, as it has built a strong footprint worldwide, and has multiple sources of rare earths and raw minerals Merck Group yesterday said it would ramp up production next year at its new flagship facility in Kaohsiung’s Lujhu District (路竹) to satisfy growing demand for advanced semiconductor materials and specialty gases, and to address supply resilience issues amid mounting geopolitical risks. Merck made the remarks during a news conference before the inauguration of its 500 million euros (US$582.1 million) facility, which is also to supply other markets in the Asia-Pacific region, it said. Merck executive board deputy chair and electronics CEO Kai Beckmann told reporters the company adopted a “local-for-local” strategy about seven years ago to address the cycle time of
Two companies wholly owned by the daughter of the founder of Hon Hai Precision Industry Co (鴻海精密) on Monday reported to the Taiwan Stock Exchange that they would dispose of all of the Hon Hai shares they hold. In filings with the exchange, Hong Wei Investment Co (鋐維) said it would sell the 2.771 million Hon Hai shares it holds and Frontier Investment Corp (承鋒投資) said it would sell its 2.409 million Hon Hai shares from tomorrow until Jan. 3 next year. The two companies are wholly owned and chaired by Shirley Gou (郭曉玲), the eldest daughter of Hon Hai founder Terry
RIDING THE WAVE: The race to build AI infrastructure has lifted the valuations of top memory makers, such as Micron, amid dwindling inventories and supply challenges Micron Technology Inc is to spend ￥1.5 trillion (US$9.6 billion) to build a plant in western Japan to make memory chips for artificial intelligence (AI) applications, the Nikkei reported on Saturday. The move comes as Micron seeks to diversify advanced chip production outside of Taiwan, the Nikkei article said, citing people familiar with the matter. The new factory will manufacture high-bandwidth memory (HBM) chips, a key component for working with AI processors such as those made by Nvidia Corp, the report said. Micron would build the facility within the compound of its Hiroshima plant, starting in May next year, with plans to launch
RSS